---
$id: https://graph.org.ai/products/commodity/51142032
$type: Product
source: UNSPSC
code: "51142032"
title: "Prednazate"
class: "51142000"
classTitle: "Non narcotic analgesics and antipyretics"
family: "51140000"
familyTitle: "Central nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Prednazate

**UNSPSC Code**: 51142032
**Class**: [Non narcotic analgesics and antipyretics](Non narcotic analgesics and antipyretics.mdx)
**Family**: [Central nervous system drugs](../Central nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an analgesic and antipyretic, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 71099P640P. European Medicines Agency schedules Prednazate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10013MIG. Prednazate generally arises in the molecular formula C25H32O8.C21H26CLN3OS. The term PREDNAZATE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 21 no. 12 1967, list 7.) PREDNAZATE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule prednazate under HS 29372900 and SITC 54153. As of Q4 2014, PREDNAZATE remains the US FDA Preferred Term for this commodity. Prednazate bears US NLM identifiers UMLS ID C2826062 and NCI Concept Code C82228. SMILES: CLC1CC2N(CCCN3CCN(CC3)CCO)C3C(SC2CC1)CCCC3.OC1(C2(C(C3C(C(O)C2)C2(C(=CC(=O)C=C2)CC3)C)CC1)C)C(=O)COC(=O)CCC(=O)O.

